rs274559
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003060.4(SLC22A5):c.652+77A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.408 in 1,410,966 control chromosomes in the GnomAD database, including 122,934 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.41 ( 13069 hom., cov: 32)
Exomes 𝑓: 0.41 ( 109865 hom. )
Consequence
SLC22A5
NM_003060.4 intron
NM_003060.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.500
Publications
34 publications found
Genes affected
SLC22A5 (HGNC:10969): (solute carrier family 22 member 5) Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]
SLC22A5 Gene-Disease associations (from GenCC):
- systemic primary carnitine deficiency diseaseInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, G2P, Orphanet, PanelApp Australia, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
- short QT syndromeInheritance: AR Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 5-132384378-A-G is Benign according to our data. Variant chr5-132384378-A-G is described in ClinVar as Benign. ClinVar VariationId is 25383.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.651 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.406 AC: 61637AN: 151922Hom.: 13060 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
61637
AN:
151922
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.408 AC: 514164AN: 1258924Hom.: 109865 AF XY: 0.417 AC XY: 265197AN XY: 636706 show subpopulations
GnomAD4 exome
AF:
AC:
514164
AN:
1258924
Hom.:
AF XY:
AC XY:
265197
AN XY:
636706
show subpopulations
African (AFR)
AF:
AC:
10472
AN:
29462
American (AMR)
AF:
AC:
14423
AN:
44366
Ashkenazi Jewish (ASJ)
AF:
AC:
9980
AN:
24920
East Asian (EAS)
AF:
AC:
25865
AN:
38702
South Asian (SAS)
AF:
AC:
51057
AN:
82210
European-Finnish (FIN)
AF:
AC:
26043
AN:
51672
Middle Eastern (MID)
AF:
AC:
2227
AN:
4754
European-Non Finnish (NFE)
AF:
AC:
351728
AN:
929198
Other (OTH)
AF:
AC:
22369
AN:
53640
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
16045
32090
48135
64180
80225
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
10378
20756
31134
41512
51890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.406 AC: 61679AN: 152042Hom.: 13069 Cov.: 32 AF XY: 0.417 AC XY: 30955AN XY: 74292 show subpopulations
GnomAD4 genome
AF:
AC:
61679
AN:
152042
Hom.:
Cov.:
32
AF XY:
AC XY:
30955
AN XY:
74292
show subpopulations
African (AFR)
AF:
AC:
14892
AN:
41494
American (AMR)
AF:
AC:
5381
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
AC:
1442
AN:
3468
East Asian (EAS)
AF:
AC:
3463
AN:
5174
South Asian (SAS)
AF:
AC:
3090
AN:
4818
European-Finnish (FIN)
AF:
AC:
5391
AN:
10542
Middle Eastern (MID)
AF:
AC:
139
AN:
294
European-Non Finnish (NFE)
AF:
AC:
26837
AN:
67956
Other (OTH)
AF:
AC:
828
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1876
3752
5627
7503
9379
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
594
1188
1782
2376
2970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2145
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Renal carnitine transport defect Benign:3
Jan 23, 2019
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jun 15, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.